Case Study: Juvenile Arthritis Trials—Meds, School & Biologics Success
A story-driven case study following Ben and his family through juvenile arthritis trials—balancing meds, school planning, flu-season safety, and choices about biologics and biosimilars with insights from clinical research coordinators.
Robert Maxwell
Sep 22, 2025
autoimmune biologics
juvenile idiopathic arthritis
biosimilar studies
vaccine safety autoimmune
